Article
A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis.
Neurology - 1 Aug 1997
Wingerchuk D, Liu Q, Sobell J, Sommer S, Weinshenker B G
Abstract excerpt
Tumor necrosis factor alpha (TNF alpha) expression is enhanced in patients with active MS and other inflammatory diseases. A guanine-to-adenine polymorphism at position -308 of the TNF alpha promoter region (the TNF2 allele) is associated with increased TNF alpha expression. We evaluated 110 MS patients derived from an Olmsted County, MN, prevalence study. Three other patient cohorts (autoimmune, serious...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
